Changes in prostaglandin E2 in patients with idiopathic overactive bladder syndrome after botulinum toxin type A treatment: is there a clinical benefit?-Reference-Cited by-同舟云学术

Changes in prostaglandin E2 in patients with idiopathic overactive bladder syndrome after botulinum toxin type A treatment: is there a clinical benefit?

Published:2014-11-04 Issue:1 Volume:14 Page:
ISSN:1471-2490
Container-title:BMC Urology
language:en
Short-container-title:BMC Urol

Author:

Hegele Axel,Knippschild Sonja,Frohme Carsten,Hänze Jörg,Olbert Peter,Hofmann Rainer

Publisher

Springer Science and Business Media LLC

Subject

Urology,Reproductive Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/1471-2490-14-85.pdf

Reference30 articles.

1. Milsom I, Abrams P, Cardozo L, Roberts RG, Thuroff J, Wein AJ: How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001, 87: 760-766.

2. Milsom I, Kaplan SA, Coyne KS, Sexton CC, Kopp ZS: Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS. Urology. 2012, 80: 90-96. 10.1016/j.urology.2012.04.004.

3. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, Van Kerrebroeck P, Victor A, Wein A, Standardisation Sub-Committee of the International Continence Society: The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003, 61: 37-49. 10.1016/S0090-4295(02)02243-4.

4. Knippschild S, Frohme C, Olbert P, Hofmann R, Hegele A: Value of nerve growth factor levels in overactive bladder syndrome: alterations after botulinum toxin therapy. Urologe A. 2012, 51: 379-383. 10.1007/s00120-011-2726-0.

5. Liu HT, Tyagi P, Chancellor MB, Kuo HC: Urinary nerve growth factor but not prostaglandin E2 increases in patients with interstitial cystitis/bladder pain syndrome and detrusor overactivity. BJU Int. 2010, 106: 1681-1685. 10.1111/j.1464-410X.2009.08851.x.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peripheral and central neurobiological effects of botulinum toxin A (BoNT/A) in neuropathic pain: a systematic review;Pain;2024-03-05

2. The mast cell stimulator compound 48/80 causes urothelium-dependent increases in murine urinary bladder contractility;American Journal of Physiology-Renal Physiology;2023-07-01

3. Therapie der weiblichen Harninkontinenz;Die Urologie;2023

4. Therapie der weiblichen Harninkontinenz;Die Urologie;2022

5. Suppression of Inflammatory and Fibrotic Signals by Cinnamon (Cinnamomum cassia) and Cinnamaldehyde in Cyclophosphamide-Induced Overactive Bladder in Mice;Evidence-Based Complementary and Alternative Medicine;2021-12-22